Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies

Busulfan (Bu)-containing regimens are commonly used in myeloablative regimens prior to allogeneic hematopoietic cell transplantation (HCT). Yet, there is considerable variability on how Bu is administered related to frequency (four times a day, Q6 or daily, Q24) and the combination with other chemot...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biol Blood Marrow Transplant
Main Authors: Pasquini, Marcelo C., Le-Rademacher, Jennifer, Zhu, Xiaochun, Artz, Andrew, DiPersio, John, Fernandez, Hugo, Mineishi, Shin, Kamishohara, Masaru, Mehta, Jayesh, Nakamura, Yuki, Ratanatharathorn, Voravit, Sobecks, Ronald, Burkart, Jeanne, Bredeson, Christopher
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4949158/
https://ncbi.nlm.nih.gov/pubmed/27154848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.04.013
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki